These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2576143)

  • 21. Potentiation of physical dependence on diazepam by ondansetron in rats.
    Mizoguchi H; Shirayama N; Tsuda M; Yoshiike M; Suzuki T; Misawa M
    Life Sci; 1994; 54(9):PL131-6. PubMed ID: 8114607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attenuation of benzodiazepine withdrawal anxiety in the rat by serotonin antagonists.
    Begg DP; Hallam KT; Norman TR
    Behav Brain Res; 2005 Jun; 161(2):286-90. PubMed ID: 15922055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Behavioural effects in mice of subchronic buspirone, ondansetron and tianeptine. I. Social interactions.
    Cutler MG; Rodgers RJ; Jackson JE
    Pharmacol Biochem Behav; 1997 Feb; 56(2):287-93. PubMed ID: 9050087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anxiolytic activity of SC-48274 compared with those of buspirone and diazepam in experimental anxiety models.
    Ogawa N; Hara C; Takaki S
    Jpn J Pharmacol; 1993 Feb; 61(2):115-21. PubMed ID: 8096257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The antagonism of benzodiazepine withdrawal effects by the selective cholecystokininB receptor antagonist CI-988.
    Singh L; Field MJ; Vass CA; Hughes J; Woodruff GN
    Br J Pharmacol; 1992 Jan; 105(1):8-10. PubMed ID: 1350747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral effects of diazepam in the murine plus-maze: flumazenil antagonism of enhanced head dipping but not the disinhibition of open-arm avoidance.
    Dalvi A; Rodgers RJ
    Pharmacol Biochem Behav; 1999 Apr; 62(4):727-34. PubMed ID: 10208379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of anxiolytic action of ondansetron in rats during withdrawal from chronic chlordiazepoxide.
    Rezazadeh SM; Prather PL; Emmett-Oglesby MW; Lal H
    Ann N Y Acad Sci; 1992 Jun; 654():472-3. PubMed ID: 1352955
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
    Costall B; Domeney AM; Naylor RJ; Tyers MB
    Br J Pharmacol; 1987 Dec; 92(4):881-94. PubMed ID: 2962686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ketotifen and its analogues reduce aversive responding in the rodent.
    Barnes NM; Costall B; Kelly ME; Onaivi ES; Naylor RJ
    Pharmacol Biochem Behav; 1990 Dec; 37(4):785-93. PubMed ID: 1965515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antagonists at the serotonin-3 receptor can reduce the fear-potentiated startle response in the rat: evidence for different types of anxiolytic activity?
    Nevins ME; Anthony EW
    J Pharmacol Exp Ther; 1994 Jan; 268(1):248-54. PubMed ID: 7905528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug challenges reveal differences in mediation of stress facilitation of voluntary alcohol drinking and withdrawal-induced anxiety in alcohol-preferring P rats.
    Overstreet DH; Knapp DJ; Breese GR
    Alcohol Clin Exp Res; 2007 Sep; 31(9):1473-81. PubMed ID: 17624999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitisation of withdrawal signs following repeated withdrawal from a benzodiazepine: differences between measures of anxiety and seizure sensitivity.
    Ward BO; Stephens DN
    Psychopharmacology (Berl); 1998 Feb; 135(4):342-52. PubMed ID: 9539258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cocaine-induced anxiety: alleviation by diazepam, but not buspirone, dimenhydrinate or diphenhydramine.
    Paine TA; Jackman SL; Olmstead MC
    Behav Pharmacol; 2002 Nov; 13(7):511-23. PubMed ID: 12409990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the chronic intake of and withdrawal from diazepam on emotional reactivity and sensory information processing in rats.
    De Ross J; Castilho VM; Brandão ML; Nobre MJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):794-802. PubMed ID: 18281136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antidepressant and anxiolytic effects of alprazolam versus the conventional antidepressant desipramine and the anxiolytic diazepam in the forced swim test in rats.
    Flugy A; Gagliano M; Cannizzaro C; Novara V; Cannizzaro G
    Eur J Pharmacol; 1992 Apr; 214(2-3):233-8. PubMed ID: 1355436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioral effects of U-78875, a quinoxalinone anxiolytic with potent benzodiazepine antagonist activity.
    Tang AH; Franklin SR; Himes CS; Ho PM
    J Pharmacol Exp Ther; 1991 Oct; 259(1):248-54. PubMed ID: 1681085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroanatomical sites of action of 5-HT3 receptor agonist and antagonists for alteration of aversive behaviour in the mouse.
    Costall B; Kelly ME; Naylor RJ; Onaivi ES; Tyers MB
    Br J Pharmacol; 1989 Feb; 96(2):325-32. PubMed ID: 2522335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-anxiety effects of Apocynum venetum L. in the elevated plus maze test.
    Grundmann O; Nakajima J; Seo S; Butterweck V
    J Ethnopharmacol; 2007 Apr; 110(3):406-11. PubMed ID: 17101250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benzodiazepine-withdrawal-induced gastric emptying disturbances in rats: evidence for serotonin receptor involvement.
    Bonnafous C; Lefevre P; Bueno L
    J Pharmacol Exp Ther; 1995 Jun; 273(3):995-1000. PubMed ID: 7791133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ondansetron--the first highly selective 5-HT3 antagonist in therapy of psychiatric diseases].
    Broocks A
    Fortschr Neurol Psychiatr; 1992 Jun; 60(6):227-36. PubMed ID: 1386589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.